| Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naive social phobia patients MM Bergamaschi, RHC Queiroz, MHN Chagas, DCG De Oliveira, ... Neuropsychopharmacology 36 (6), 1219-1226, 2011 | 991 | 2011 |
| Opposite effects of Δ-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology S Bhattacharyya, PD Morrison, P Fusar-Poli, R Martin-Santos, ... Neuropsychopharmacology 35 (3), 764-774, 2010 | 889 | 2010 |
| Safety and side effects of cannabidiol, a Cannabis sativa constituent M Machado Bergamaschi, R Helena Costa Queiroz, A Waldo Zuardi, ... Current drug safety 6 (4), 237-249, 2011 | 764 | 2011 |
| Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report JAS Crippa, GN Derenusson, TB Ferrari, L Wichert-Ana, FLS Duran, ... Journal of psychopharmacology 25 (1), 121-130, 2011 | 705 | 2011 |
| Alcohol Use Disorders Identification Test (AUDIT): An updated systematic review of psychometric properties. C de Meneses-Gaya, AW Zuardi, SR Loureiro, JAS Crippa Psychology & Neuroscience 2 (1), 83, 2009 | 689 | 2009 |
| Cannabis and anxiety: a critical review of the evidence JA Crippa, AW Zuardi, R Martín‐Santos, S Bhattacharyya, Z Atakan, ... Human Psychopharmacology: Clinical and Experimental 24 (7), 515-523, 2009 | 669 | 2009 |
| Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report FL Osório, RF Sanches, LR Macedo, RG Dos Santos, JP Maia-de-Oliveira, ... Revista brasileira de psiquiatria 37 (1), 13-20, 2015 | 623 | 2015 |
| Distinct effects of Δ9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing P Fusar-Poli, JA Crippa, S Bhattacharyya, SJ Borgwardt, P Allen, ... Archives of general psychiatry 66 (1), 95-105, 2009 | 619 | 2009 |
| Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug AW Zuardi, JAS Crippa, JEC Hallak, FA Moreira, FS Guimarães Brazilian journal of medical and biological research 39, 421-429, 2006 | 603 | 2006 |
| Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a SPECT study RF Sanches, F de Lima Osório, RG Dos Santos, LRH Macedo, ... Journal of clinical psychopharmacology 36 (1), 77-81, 2016 | 570 | 2016 |
| Structural and functional imaging studies in chronic cannabis users: a systematic review of adolescent and adult findings A Batalla, S Bhattacharyya, M Yuecel, P Fusar-Poli, JA Crippa, S Nogue, ... PloS one 8 (2), e55821, 2013 | 514 | 2013 |
| The psychedelic state induced by ayahuasca modulates the activity and connectivity of the default mode network F Palhano-Fontes, KC Andrade, LF Tofoli, AC Santos, JAS Crippa, ... PloS one 10 (2), e0118143, 2015 | 510 | 2015 |
| Cannabidiol for the treatment of psychosis in Parkinson’s disease AW Zuardi, JAS Crippa, JEC Hallak, JP Pinto, MHN Chagas, ... Journal of Psychopharmacology 23 (8), 979-983, 2009 | 455 | 2009 |
| Effects of cannabidiol in the treatment of patients with Parkinson’s disease: an exploratory double-blind trial MHN Chagas, AW Zuardi, V Tumas, MA Pena-Pereira, ET Sobreira, ... Journal of Psychopharmacology 28 (11), 1088-1098, 2014 | 440 | 2014 |
| Confiabilidade da" Entrevista Clínica Estruturada para o DSM-IV-Versão Clínica" traduzida para o português CM Del-Ben, JAA Vilela, JAS Crippa, JEC Hallak, CM Labate, AW Zuardi Brazilian Journal of Psychiatry 23, 156-159, 2001 | 389 | 2001 |
| Neuroimaging in social anxiety disorder: a systematic review of the literature MC Freitas-Ferrari, JEC Hallak, C Trzesniak, A Santos Filho, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 34 (4), 565-580, 2010 | 376 | 2010 |
| Effects of cannabidiol (CBD) on regional cerebral blood flow JAS Crippa, AW Zuardi, GEJ Garrido, L Wichert-Ana, R Guarnieri, ... Neuropsychopharmacology 29 (2), 417-426, 2004 | 373 | 2004 |
| Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the … RG Dos Santos, FL Osório, JAS Crippa, J Riba, AW Zuardi, JEC Hallak Therapeutic advances in psychopharmacology 6 (3), 193-213, 2016 | 369 | 2016 |
| Translational investigation of the therapeutic potential of cannabidiol (CBD): toward a new age JA Crippa, FS Guimarães, AC Campos, AW Zuardi Frontiers in immunology 9, 2009, 2018 | 363 | 2018 |
| The role of dopamine in reward and pleasure behaviour–review of data from preclinical research RA Bressan, JA Crippa Acta Psychiatrica Scandinavica 111, 14-21, 2005 | 359 | 2005 |
